Strategic Initiative

Slingshot members are tracking this corporate initiative:

Vyleesi approval in U.S. triggers a $60 million milestone payment to Palatin(PTN) under its North American license agreement with AMAG

Source Link:: https://www.prnewswire.com/news-releases/fda-approves-new-drug-application-for-vyleesi-bremelanotide-injection-300873013.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

100%

Strategic Initiative Date

Announcement Date:

Jun 21, 2019

Projected Implementation:

Q2, 2019

Relevance Tracked Until:

Q3, 2019

Related Projects

Related Keywords Vyleesi, Milestone Payment, Hypoactive Sexual Desire Disorder, Premenopausal Women